662 F.Supp.3d 581
D. Md.2023Background
- PETA, an animal-protection nonprofit, challenges NIH/HHS funding of mice-involved sepsis research it says inflicts needless pain and lacks translatability to humans.
- Scientific literature and an NIH working group raised substantial doubt that mice are a valid model for human sepsis; PETA sent a detailed letter to NIH on October 23, 2019.
- NIH replied it would take PETA’s concerns "under advisement" but continued to approve sepsis grants; the Complaint identifies five specific mice-involved grants awarded after PETA’s letter.
- On September 20, 2021, PETA sued under the Administrative Procedure Act, alleging NIH’s grant approvals since October 23, 2019 (including the five named awards) were arbitrary and capricious.
- Defendants moved to dismiss for lack of Article III standing and for failure to state an APA claim; the court heard the motion on the briefs.
- Ruling: the court denied dismissal for lack of standing (PETA has organizational standing), dismissed overbroad claims challenging all post‑letter NIH sepsis approvals and a pattern‑and‑practice claim (Count Two), and allowed PETA’s APA arbitrary-and-capricious challenge to proceed as to the five specifically named grants.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Article III standing (organizational injury) | PETA alleges mission frustration and diversion of resources (public campaigns, letters, education) caused by NIH funding of animal sepsis research. | PETA’s expenditures are plaintiff’s own choices; no concrete, particularized injury traceable to NIH. | PETA has organizational standing: diversion of resources to counteract NIH conduct is a concrete injury fairly traceable and redressable. |
| Existence of a "final agency action" under the APA | NIH’s awards of the identified grants are final agency actions (agency’s decisionmaking consummated by award). | Grants not yet disbursed or generalized grant policies are not final actions. | The five enumerated grant approvals are final actions; generalized challenges to all post‑letter approvals are too diffuse and are dismissed. |
| Reviewability / Committed to agency discretion | NIH’s statutory/regulatory grant criteria (peer review and factors including animal protection) provide judicially manageable standards. | Grantmaking is committed to agency discretion by law and therefore unreviewable. | Not committed to unreviewable discretion; statutes/regulations supply standards allowing review of the five named grants. |
| Arbitrary and capricious claim (merits, pleading) | NIH ignored long‑standing peer‑review literature and an NIH working group casting doubt on mice as a model, failing to consider adequacy of methods and animal protections. | NIH followed its established peer‑review process; PETA’s allegations are insufficient. | At pleading stage, PETA plausibly alleges NIH’s decisions may be arbitrary and capricious as to the five grants; claim survives dismissal. |
Key Cases Cited
- Havens Realty Corp. v. Coleman, 455 U.S. 363 (organizational standing via diversion of resources)
- Friends of the Earth, Inc. v. Laidlaw Env’t Servs., 528 U.S. 167 (standing and redressability principles)
- Bennett v. Spear, 520 U.S. 154 (final agency action test)
- Norton v. S. Utah Wilderness All., 542 U.S. 55 (limits on APA judicial review)
- Vill. of Bald Head Island v. U.S. Army Corps of Eng’rs, 714 F.3d 186 (APA claims must attack discrete agency action)
- Weyerhaeuser Co. v. U.S. Fish & Wildlife Serv., 139 S. Ct. 361 (narrow scope of "committed to agency discretion" exception)
- Lexmark Int’l, Inc. v. Static Control Components, Inc., 572 U.S. 118 (zone-of-interests test)
- Motor Vehicle Mfrs. Ass’n v. State Farm, 463 U.S. 29 (arbitrary-and-capricious standard)
- Massachusetts v. EPA, 549 U.S. 497 (redressability does not require relief to solve every harm)
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (pleading standard)
- Ashcroft v. Iqbal, 556 U.S. 662 (pleading standard)